System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Sherif Bayoumy is an expert in Neurology at Leiden University Medical Center (Netherlands). Sherif Bayoumy has authored 11 publications, the most recent in 2025. SLR score: 47 (community average: 125). How the SLR is computed.

LeadR Profile

Sherif Bayoumy Leiden University Medical Center Netherlands
47 ScienceLeadR Reputation 47

Unlock

Register Login
Network Map

Neurology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2015 - 2026
Source: PubMed

Leiden University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 11

Citations

Citations: 328 1st author: 5 Last author: 1 Unique author: 0

Main journals

Alzheimers Res Ther 3
Alzheimers Dement 1
Clin Chem Lab Med 1
Commun Biol 1
Front Neurol 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer's disease.
PMID 40229846 — epitopes, alzheimer disease, cognitive dysfunction, biomarkers, synucleins		Alzheimers Res Ther20250
Analytical and clinical performance of eight Simoa and Lumipulse assays for automated measurement of plasma p-tau181 and p-tau217.
PMID 39702308 — research design, alzheimer disease, plasma		Alzheimers Res Ther202416
Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
PMID 38215341 — muscular atrophy, spinal, child, biomarkers, therapeutics, disease management, genes, spine, blood, tumor necrosis factor ligand superfamily member 14		Clin Chem Lab Med202416
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
PMID 38323780 — research design, dementia, alzheimer disease, probability, cognitive dysfunction, biomarkers, plasma		Alzheimers Dement202422
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.
PMID 37557955 — dementia, biomarkers, brain, cells, precision medicine, immunoassay, technology, research, blood, proteome		Mol Cell Proteomics202322

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS